THREAD Configurable SaaS Technology Awarded DiMe Seal in Inaugural Batch of Digital Health Innovators
THREAD Configurable SaaS Technology Awarded DiMe Seal in Inaugural Batch
CARY, N.C., 09 JUL 2025 – Since its initial launch in 2018, THREAD’s no-code SaaS research platform has been focused on innovating technology implementation and endpoint data capture to enable clinical research for everyone, everywhere. The platform has enabled global digital health solutions in clinical research studies since its debut offering hundreds of integrated devices in its configurable digital health library for use in just a few clicks. Today, the company announces its latest digital health industry recognition and award of the DiMe Seal.
This recognition from the Digital Medicine Society (DiMe) is a testament to THREAD’s commitment to creating digital health software products built for quality and trust. As the professional organization advancing the practice of digital medicine, DiMe engaged its cross-disciplinary community of experts to create the first-ever comprehensive framework defining best practices in evidence, usability, privacy, security, and equity of digital health software products.
"This award is yet another example of the great product our amazing team has built and why our clients trust us to deliver the most complex clinical trials with them,” said John Reites, Co-founder and CEO at THREAD. “We have been conducting digital health studies since 2016 and we’re proud to complete this validation process as another step in our commitment to the highest quality solutions for our clients.”
Learn more about THREAD’s DiMe Seal award, see a demo of our digital health solutions, and explore how we support sponsors to remove legacy systems, reduce costs and remove risks in deploying their research studies: www.threadresearch.com
##
About THREAD
THREAD’s® purpose is to leverage its clinical research platform to enable studies for everyone, everywhere. The companies’ uniquely combined clinical research technology and consulting services help life science organizations to design, operate, and scale next-generation research studies and electronic clinical outcome assessments (eCOA) programs for participants, sites, and study teams. Through its comprehensive platform and scientific expertise, THREAD empowers studies to be accessible, efficient, and centered on the patient. THREAD is recognized as a leader by Everest Group’s Decentralized Clinical Trial Product PEAK Matrix® Assessment 2021/2022/2023 and positioned in the Leader's Category of the 2022 IDC MarketScape for R&D Decentralized Clinical Trial Technology Solutions Vendor Assessment 2022. Visit THREADresearch.com to learn more.
Media Contact
Les Yates
THREAD
media@THREADresearch.com